139 related articles for article (PubMed ID: 30064682)
1. Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations.
Binet Q; Lambert C; Hermans C
Thromb Res; 2018 Aug; 168():114-120. PubMed ID: 30064682
[TBL] [Abstract][Full Text] [Related]
2. Dabigatran etexilate versus low-molecular weight heparin to control consumptive coagulopathy secondary to diffuse venous vascular malformations.
Ardillon L; Lambert C; Eeckhoudt S; Boon LM; Hermans C
Blood Coagul Fibrinolysis; 2016 Mar; 27(2):216-9. PubMed ID: 26484645
[TBL] [Abstract][Full Text] [Related]
3. Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations.
Liu H; Hu L; Yang X; Xu Z; Gu H; Chen H; Lin X
J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):397-403.e1. PubMed ID: 36328137
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series.
Mack JM; Richter GT; Crary SE
Lymphat Res Biol; 2018 Jun; 16(3):278-281. PubMed ID: 29583078
[TBL] [Abstract][Full Text] [Related]
5. Effect of sirolimus on coagulopathy of slow-flow vascular malformations.
Mack JM; Verkamp B; Richter GT; Nicholas R; Stewart K; Crary SE
Pediatr Blood Cancer; 2019 Oct; 66(10):e27896. PubMed ID: 31250546
[TBL] [Abstract][Full Text] [Related]
6. Coagulopathy and related complications following sclerotherapy of congenital venous malformations.
Swerdlin RF; Briones MA; Gill AE; Hawkins CM
Pediatr Blood Cancer; 2022 May; 69(5):e29610. PubMed ID: 35234344
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with dabigatran for consumptive coagulopathy associated with extensive vascular malformations.
Yasumoto A; Ishiura R; Narushima M; Yatomi Y
Blood Coagul Fibrinolysis; 2017 Dec; 28(8):670-674. PubMed ID: 28938309
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy.
Ricci KW; Chute C; Hammill AM; Dasgupta R; Patel M
Pediatr Blood Cancer; 2020 Oct; 67(10):e28277. PubMed ID: 32779831
[TBL] [Abstract][Full Text] [Related]
9. MRI phenotypes of localized intravascular coagulopathy in venous malformations.
Koo KS; Dowd CF; Mathes EF; Rosbe KW; Hoffman WY; Frieden IJ; Hess CP
Pediatr Radiol; 2015 Oct; 45(11):1690-5. PubMed ID: 26143286
[TBL] [Abstract][Full Text] [Related]
10. Association of localized intravascular coagulopathy with venous malformations.
Dompmartin A; Acher A; Thibon P; Tourbach S; Hermans C; Deneys V; Pocock B; Lequerrec A; Labbé D; Barrellier MT; Vanwijck R; Vikkula M; Boon LM
Arch Dermatol; 2008 Jul; 144(7):873-7. PubMed ID: 18645138
[TBL] [Abstract][Full Text] [Related]
11. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
Baetz BE; Spinler SA
Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996
[TBL] [Abstract][Full Text] [Related]
12. Venous Malformation and Localized Intravascular Coagulopathy in Children.
Hung JW; Leung MW; Liu CS; Fung DH; Poon WL; Yam FS; Leung YC; Chung KL; Tang PM; Chao NS; Liu KK
Eur J Pediatr Surg; 2017 Apr; 27(2):181-184. PubMed ID: 27089461
[No Abstract] [Full Text] [Related]
13. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.
Stangier J; Rathgen K; Stähle H; Gansser D; Roth W
Br J Clin Pharmacol; 2007 Sep; 64(3):292-303. PubMed ID: 17506785
[TBL] [Abstract][Full Text] [Related]
14. Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography.
Mack JM; Pierce CD; Richter GT; Spray BJ; Nicholas R; Lewis PS; Becton D; Crary SE
Pediatr Blood Cancer; 2021 Feb; 68(2):e28824. PubMed ID: 33211399
[TBL] [Abstract][Full Text] [Related]
15. Giant intrahepatic venous malformation with localized intravascular coagulopathy. Follow-up and treatment during pregnancy.
Serrano F; Bisdorff-Bresson A; Sroussi J; Aymard A; Wassef M; Civelli V; Boujlel S; Houdart E; Drouet L
J Med Vasc; 2020 Dec; 45(6):309-315. PubMed ID: 33248533
[TBL] [Abstract][Full Text] [Related]
16. A novel coagulation parameter monitoring bleeding tendency of Chinese nonvalvular atrial fibrillation patients prescribing dabigatran etexilate.
Wang H; Zhou Y; Rong G; Lu L; Zhang J
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):563-7. PubMed ID: 26881855
[TBL] [Abstract][Full Text] [Related]
17. Localised intravascular coagulation complicating venous malformations in children: Associations and therapeutic options.
Zhuo KY; Russell S; Wargon O; Adams S
J Paediatr Child Health; 2017 Aug; 53(8):737-741. PubMed ID: 28169477
[TBL] [Abstract][Full Text] [Related]
18. Localized intravascular coagulation in venous malformations: A system review.
Han YY; Sun LM; Yuan SM
Phlebology; 2021 Feb; 36(1):38-42. PubMed ID: 32731789
[TBL] [Abstract][Full Text] [Related]
19. [Venous malformations and coagulopathy].
Hermans C; Dessomme B; Lambert C; Deneys V
Ann Chir Plast Esthet; 2006; 51(4-5):388-93. PubMed ID: 17005308
[TBL] [Abstract][Full Text] [Related]
20. Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome.
Mazoyer E; Enjolras O; Laurian C; Houdart E; Drouet L
Clin Lab Haematol; 2002 Aug; 24(4):243-51. PubMed ID: 12181029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
